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Abstract
Endoplasmic reticulum (ER) stress is characterized by the accumulation of misfolded pro-
teins due to an impairment of ER quality control pathways leading to the activation of a
defense system, called unfolded protein response (UPR). While thyrocytes are supposed to
be highly susceptible to environmental conditions that cause ER stress due to the synthesis
of large amounts of secretory proteins required for thyroid hormone synthesis, systematic
investigations on the effect of ER stress on expression of key genes of thyroid hormone
synthesis and their transcriptional regulators are lacking. Since the aim of the ER stress-
induced UPR is to restore ER homeostasis and to facilitate cell survival through transient
shutdown of ribosomal protein translation, we hypothesized that the expression of genes
involved in thyroid hormone synthesis and their transcriptional regulators, all of which are
not essential for cell survival, are down-regulated in thyrocytes during ER stress, while sterol
regulatory element-binding proteins (SREBPs) are activated during ER stress in thyrocytes.
Treatment of FRTL-5 thyrocytes with the ER stress inducer tunicamycin (TM) dose-depen-
dently increased the mRNA and/or protein levels of known UPR target genes, stimulated
phosphorylation of the ER stress sensor protein kinase RNA-like ER kinase (PERK) and of
the PERK target protein eukaryotic initiation factor 2α (eIF2α) and caused splicing of the ER
stress-sensitive transcription factor X-box binding protein (XBP-1) (P < 0.05). The mRNA
levels and/or protein levels of genes involved in thyroid hormone synthesis, sodium/iodide
symporter (NIS), thyroid peroxidase (TPO) and thyroglobulin (TG), their transcriptional regu-
lators and thyrotropin (TSH) receptor and the uptake of Na125I were reduced at the highest
concentration of TM tested (0.1 μg/mL; P < 0.05). Proteolytic activation of the SREBP-1c
pathway was not observed in FRTL-5 cells treated with TM, whereas TM reduced proteolytic
activation of the SREBP-2 pathway at 0.1 μg TM/mL (P < 0.05). In conclusion, the expres-
sion of key genes involved in thyroid hormone synthesis and their critical regulators and of
the TSH receptor as well as the uptake of iodide is attenuated in thyrocytes during mild ER
stress. Down-regulation of NIS, TPO and TG during ER stress is likely the consequence of
impaired TSH/TSHR signaling in concert with reduced expression of critical transcriptional
regulators of these genes.
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Introduction
One major function of the endoplasmic reticulum (ER) is to maintain the integrity of newly
synthesized proteins by partitioning proteins between ER folding, trafficking and degradation
pathways in a process called ER quality control [1]. Proteins that enter co-translationally the
ER are folded into their functional conformations with the help of ER-localized chaperones
and folding factors and then packaged into vesicles for trafficking to secretory environments.
However, misfolded proteins are directed towards the ER-associated degradation (ERAD)
pathway, where they are translocated to the cytosol and degraded by the ubiquitin proteasome
system [2].
As a consequence of different environmental and genetic stressors, imbalances in ER
quality control pathways can be induced leading to the accumulation of misfolded proteins,
a condition termed ER stress [3]. In order to combat ER stress, eukaryotic cells from yeast
to mammals have evolved a defense system, called unfolded protein response (UPR), which
aims to re-establish ER quality control and to decrease ER accumulation of misfolded pro-
teins [4,5]. The UPR is a tripartite signaling pathway activated by three transmembrane ER
proteins sensing the accumulation of misfolded proteins: ATF6 (activating transcription
factor 6), IRE1 (inositol-requiring protein 1a) and PERK (protein kinase RNA-like ER
kinase). One important effect of the UPR, which is mediated by PERK-dependent phos-
phorylation/inactivation of eukaryotic initiation factor 2α (eIF2α), is transient attenuation
of new protein synthesis leading to a decrease of newly synthesized proteins entering the
ER, thereby reducing the load of ER folding and degradation pathways and enabling the
ER to better cope with misfolded proteins accumulating during ER stress [5,6]. ER
protein folding load is also reduced through an IRE1-dependent mRNA degradation mech-
anism abbreviated as RIDD (regulated IRE1-dependent decay of mRNA) [7], thereby, lead-
ing to a decrease of proteins entering co-translationally the ER. A further important effect
mediated by IRE1 is unconventional mRNA splicing of X-box binding protein (XBP)-1,
which leads to the production of the active transcription factor sXBP-1 inducing genes
involved in chaperoning, disulfide isomerization, N-glycosylation and vesicular trafficking
[8]. ER quality control capacity is also improved as a consequence of the UPR due to activa-
tion of ATF6, a transcription factor inducing genes involved in protein folding and degrada-
tion [9].
Thyrocytes are highly specialized polarized epithelial cells that synthesize large amounts
of secretory proteins required for thyroid hormone synthesis and are therefore particularly
susceptible to environmental conditions that cause ER stress, as shown recently [10,11].
Indeed, evidence exists that ER stress/UPR plays a pathophysiological role in different thy-
roid disorders including congenital hypothyroid goiter [11–13], cystinosis-induced hypothy-
roidism [14] and amiodarone-induced destructive thyroiditis [15]. In line with this, it has
been reported that ER stress impairs glycosylation of thyroglobulin (TG), a major secretory
protein of the thyrocyte, and ER retention of TG [10]. TG is a large glycoprotein secreted
from the thyrocyte into the follicular lumen [16], where selected tyrosyl residues of TG
become iodinated leading to the thyroid hormone precursors mono- and diiodotyrosine
[17]. While the effect of ER stress on TG expression in thyrocytes has been extensively stud-
ied [10], systematic investigations on the effect of ER stress on expression of key genes of thy-
roid hormone synthesis and their transcriptional regulators are lacking in the literature.
Besides TG, sodium/iodide symporter (NIS) and thyroid peroxidase (TPO) play a central
role for thyroid hormone synthesis as evidenced from the fact that genetic abnormalities in
any of these key proteins leads to severe hypothyroidism [18–20]. Regulation of thyrocyte
gene expression of TG, NIS and TPO is under the control of thyrotropin (TSH), the main
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hormonal regulator of the thyroid, and involves the transcription factors thyroid transcrip-
tion factor (TTF)-1, forkhead box E1 (FOXE1, also named TTF-2) and paired box-8 (PAX-8)
[21–25]. Since the aim of the ER stress-induced UPR is to restore ER homeostasis and to
facilitate cell survival through transient shutdown of ribosomal translation of mRNAs and
enhancing the capacity of ER protein folding and degradation pathways, we hypothesized
that the expression of genes involved in thyroid hormone synthesis and their transcriptional
regulators, all of which are not essential for cell survival, are down-regulated in thyrocytes
during ER stress.
We have recently reported that sterol regulatory element-binding proteins (SREBP)-1c and
SREBP-2, which have been initially identified as master regulators of genes involved in lipid
synthesis and uptake such as fatty acid synthase (FASN), glycerol-3-phosphate acyltransferase,
mitochondrial (GPAM), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and LDL
receptor (LDLR) [26], also act as transcriptional regulators of NIS, TPO and TG and are under
the control of TSH in thyrocytes [27–29]. Despite the role of SREBPs as transcriptional regula-
tors of NIS, TPO and TG, we hypothesized that SREBPs are activated in thyrocytes during ER
stress. This is based on observations from different groups that SREBP-1c and SREBP-2 are
activated in different cell types under ER stress conditions [30–35]. Activation of SREBPs dur-
ing ER stress is mediated by phosphorylation of the ER stress sensor PERK and is considered
as a means to synthesize membrane lipids, like fatty acids and cholesterol, which are required
for the expansion of the ER during ER stress [36]. To test our hypotheses, we used Fisher rat
thyroid cell line-5 (FRTL-5) cells, a frequently used thyrocyte model dependent on thyrotropin
(TSH) [37], which were treated with tunicamycin (TM). TM is a chemical compound inducing
ER stress through inhibiting protein glycosylation [38].
Material and methods
Cell culture
FRTL-5 cells were obtained from Cell lines service (Eppelheim, Germany). Cells were cultured
in Ham´s F12 medium supplemented with 5% newborn calf serum, 1% antibiotic-antimyco-
tic-mixture and a six-hormone mixture as described recently [29]. Medium was changed every
two days. After reaching a confluence of 70–80%, the cells were either sub-cultivated or used
for experiments.
Cell viability assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to
assess cell viability and performed according to the manufacturer´s directions (Sigma). In
brief, FRTL-5 cells were seeded in 96-well plates at a density of 5 x 104 cells per well. After
reaching confluence, cells were treated with different concentrations of TM (Sigma-Aldrich,
Taufkirchen, Germany) as indicated for 24 h. Control cells were treated with the same con-
centration of vehicle (DMSO). Cells treated with medium only were used to evaluate a possi-
ble effect of DMSO. Following treatment, medium was aspirated and cells were incubated
with MTT solution (1 mg/mL PBS) for 4 h. Finally, formazan crystals were dissolved and
absorbance was measured as described recently [39]. Cell viabilities are expressed as per-
centage of control cells (viability of control cells was set to 100%). Mean absorbance value of
vehicle control was set to 100%, and the means and SD of absorbance values of TM-treated
cells was presented relative to that of vehicle control. Three independent experiments were
run.
ER stress and thyroid hormone synthesis
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RNA isolation and quantitative real-time RT-PCR
For qPCR experiments, FRTL-5 cells were seeded in 24-well plates at a density of 1 x 105 cells
per well and treated, after reaching confluence, with the TM concentrations indicated for 24 h.
Control cells indicated as “0” were treated with the same concentration of vehicle (DMSO).
Following treatment, the medium was aspirated, the cell layer washed with PBS, and plates
immediately stored at -80˚C until RNA extraction. Total RNA was extracted from cells using
Trizol™ reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer´s protocol.
The cDNA was synthesized as described recently in detail [40]. qPCR analysis on a Rotor-
Gene Q system (Qiagen, Hilden, Germany) and calculation of mRNA levels was performed as
described recently in detail [39]. Gene-specific primer pairs were designed using Primer3 [41]
and BLAST [42] and synthesized by Eurofins MWG Operon (Ebersberg, Germany) (Table 1).
For normalization of relative expression values of target genes the method of Vandesompele
et al. [43] was used. In the present study four potential reference genes were tested (TOP1,
RPL13, ACTB, WYHAZ), from which three (TOP, RPL13, ACTB; M-values between 0.399
and 0.430; V-value V3/V4 = 0.124) were used to calculate the normalization factor as the geo-
metric mean of their expression data. Within each independent experiment, all technical repli-
cates were analyzed and a single mean was calculated for each treatment. The mean of vehicle
control (“0”) was set to 1.0 and the mean and SD of the TM-treated cells were scaled propor-
tionally in order to show the changes in mRNA levels as fold of vehicle control. Three indepen-
dent experiments were run.
Table 1. Sequences of gene-specific primers used for quantitative real-time PCR analysis.
Gene name Primer sequence (forward, reverse) Product size (bp) NCBI GenBank
Reference genes
ACTB GACCTCTATGCCAACACAGT CACCAATCCACACAGAGTAC 154 NM_031144
RPL13 CTTAAATTGGCCACGCAGCT CTTCTCAACGTCTTGCTCTG 198 XR_086310
TOP1 GAAGAACGCTATCCAGAAGG GCTTTGGGACTCAGCTTCAT 137 NM_022615
YWHAZ GACGGAAGGTGCTGAGAAA GCAGCAACCTCAGCCAAGT 198 NM_013011
Target genes
ATF4 AACACAGCCCTTCCACCTCC TGCTCAGCCCTCTTCTTCTGG 205 NM_024403
BAX AGGCGAATTGGCGATGAACT GAAGCCTCAGCCCATCTTCTTC 396 NM_017059
CHOP ACAAGCACCTCCCAAAGCCC TGCTCCTTCTCCTTCATGCGC 155 NM_001109986
BiP TCAGCCCACCGTAACAATCAAGGTCCTCAGCAAACTTCTCGGCG 282 NM_013083
FASN AGGTGCTAGAGGCCCTGCTA GTGCACAGACACCTTCCCAT 281 X62888
GPAM CAGCGTGATTGCTACCTGAA CTCTCCGTCCTGGTGAGAAG 194 U36771
HMGCR CGAGCAAGTGATTACCCTGA GTCTTGGTTCACTCCTGGAT 223 NM_013134
LDLR ACAGTGTCCTCCCAAGTCCAA GCAAATGTGGATCTCGTCCTC 221 NM_175762
NIS GCTGTGGCATTGTCATGTTC TGAGGTCTTCCACAGTCACA 219 NM_052983
PAX-8 CCTTACTCAACAGTACCCTGG AGCTAGAACTGGAGAGCTCTG 162 NM_031141
XBP-1/sXBP-1 GACACGCTTGGGGATGAATGC AGAGGCAACAGCGTCAGAATCC 192/166 NM_001004210/NM_001271731
SREBP-1c GGAGCCATGGATTGCACATT AGGAAGGCTTCCAGAGAGGA 191 NM_001276708
SREBP-2 CTGACCACAATGCCGGTAAT CTTGTGCATCTTGGCATCTG 204 NM_001033694
TG GTTCCTACGTGTACTAGTGAG CATACTGGAGTTGGAGAGCAG 196 NM_030988
TPO CAGGTGTTGAGAAGCAGTTG CTTTGAAAGCTGTAGCCAGG 255 NM_019353
TSHR CCAGAAGCTTGACTTACATAG CATGTAAGGGTTGTCTGTGAT 161 NM_012888
TTF-1 GCATGAATATGAGCGGCATGG ACTTCTGCTGCTTGAAGCGTC 153 NM_013093
TTF-2 GAAGTGGCAGAACAGCATCC 139 NM_138909
https://doi.org/10.1371/journal.pone.0187561.t001
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Immunoblotting
For immunoblotting experiments, FRTL-5 cells were seeded in 6-well plates at a density of 2
x 105 cells per well and treated, after reaching confluence, with the TM concentrations indi-
cated for 24 h. Control cells indicated as “0” were treated with the same concentration of
vehicle (DMSO). Following treatment, the medium was aspirated, the cell layer washed with
PBS and either cell lysates or subcellular fractions (nuclear fraction, cytosolic fraction) were
prepared. Within each independent experiment, two technical replicates per treatment were
pooled during preparation of cell lysates and subcellular fractions. For detection of BiP,
CHOP, PERK, eIF2α, TG, NIS, TTF-1, TTF-2 and PAX-8, cell lysates were prepared with
radioimmunoprecipitation assay (RIPA) lysis buffer [50 mM Tris (pH 7.5), 150 mM NaCl, 1
mM EDTA, 1% Triton X-100, 0.1% SDS, and 1% sodium deoxycholate] containing protease
inhibitors (Sigma-Aldrich Chemie GmbH, Germany). For detection of p-PERK, p-eIF2α
and p-TG, cell lysates were prepared with RIPA lysis buffer containing the phosphatase
inhibitors sodium fluoride (5 mM) and sodium-orthovanadat (1 mM) (both from Sigma-
Aldrich) as well as protease inhibitors (Sigma-Aldrich). For detection of nSREBP-1/2 and
pSREBP-1/2, nuclear and cytosolic extracts, respectively, were prepared with the Nuclear
Extract Kit from Active Motif (La Hulpe, Belgium) according to the manufacturer’s protocol.
Determination of protein concentrations of cell lysates and subcellular fractions, separation
of proteins by SDS-PAGE and electrotransfer to nitrocellulose membranes and blocking of
membranes were carried out as described recently (Chiappisi et al. 2017). Afterwards, mem-
branes were incubated with primary antibodies against SREBP-1 (1:300, Santa Cruz Biotech-
nology, Heidelberg, Germany), SREBP-2 (1:300, Santa Cruz Biotechnology), NIS (1:2,000,
kindly provided from Prof. N. Carrasco, New Haven, USA), TG (1:10000, Abcam, Cam-
bridge, UK), BiP (1:5,000, Thermo Fisher Scientific, Langenselbold, Germany), total and p-
eIF2α (both 1:1,000, Cell Signaling Technology, Danvers, MA, USA), total and p-PERK
(both 1:1,000, Signaling Technology), CHOP (1:2,000, Thermo Fisher Scientific), TTF-1
(1:500, Santa Cruz Biotechnology), TTF-2 (1:500, Santa Cruz Biotechnology), PAX-8 (1:500,
Santa Cruz Biotechnology), and either β-actin (1:40.000, Abcam) or vinculin (1:10,000,
Thermo Fisher Scientific) as a reference protein for normalization at 4˚C overnight. The
membranes were washed and then incubated with a horseradish peroxidase-conjugated sec-
ondary anti-rabbit-IgG (1:10,000, Sigma-Aldrich) or anti-mouse-IgG antibody (1:10,000,
Santa Cruz Biotechnology) at RT for 1.5 h. Chemiluminescence detection and quantification
of signal intensities of specific bands was carried out as described [39]. For calculation of
protein levels, the band intensity of the proteins of interest was normalized by that of β-actin.
Within one independent experiment, all technical replicates per treatment were analyzed
and a single mean was calculated for each treatment. The mean of vehicle control (concen-
tration “0”) was set to 1.0 and the mean and SD of the other concentrations were scaled pro-
portionally in order to show the changes in protein expression as fold of vehicle control.
Three independent experiments were run.
Iodide uptake
For iodide uptake, FRTL-5 cells were seeded in 24-well plates at a density of 1 x 105 cells per
well and treated, after reaching confluence, with the TM concentrations indicated for 24 h.
The uptake assay was performed as described recently [44]. In brief, the medium was removed,
cells were washed with warm (37˚C) Hank’s buffered salt solution (HBSS) and then incubated
with HBSS containing Na125I (0.3 μCi/mL) at 37˚C for 1 h. To distinguish between total iodide
uptake and NIS-specific uptake, the incubation was performed both in the absence (total
iodide uptake) and the presence (NIS-specific uptake) of 1 mM KClO4, a specific inhibitor of
ER stress and thyroid hormone synthesis
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iodide uptake via NIS. The incubation was terminated by aspiration of the medium. After rins-
ing two times with ice-cold HBSS, cells were lysed with 0.5 mL 0.5 M NaOH with shaking at
RT for 30 min. The cell lysate from each well was transferred in a counter vial for scintillation
counting (Perkin Elmer Liquid Scintillation Analyzer Tri-Carb 2900TR, Rodgau, Germany).
Na125I uptake is presented as counts per minute and well. Three independent experiments
were run.
Statistical analysis
All data represent means and SD. In all figures showing numerical data, with the exception of
data from Na125I uptake, the means and SD were calculated from the means for the same treat-
ments of three independent experiments. Data were analyzed by Student´s t-test comparing
cells of each TM concentration with the vehicle control cells (“0”) using the Minitab Statistical
Software Rel. 13.0 (Minitab, State College, PA, USA). Differences of P < 0.05 were considered
as significant.
Results and discussion
ER stress induced by TM impairs cell viability and activates the unfolded
protein response in FRTL-5 cells
Although the aim of the ER stress-induced UPR is to restore ER homeostasis and to facilitate
cell survival through transient shutdown of protein synthesis and enhancing the capacity of ER
quality control pathways, the UPR can also activate the apoptotic program of cell death if ER
stress persists chronically at high level and ER homeostasis cannot be restored [45,46]. Since
apoptosis per se interfere with other cellular functions, it is critical to investigate the cellular
response to ER stress inducers at a dose at which apoptosis is avoided, yet ER stress signaling
pathways are activated. Thus, at the beginning of the study the viability of FRTL-5 cells was
assessed in response to 24 h incubation with increasing concentrations of TM (from 0.01 to
1 μg/mL). Incubation with TM reduced FRTL-5 cell viability by 10% at the lowest concentra-
tion (not significant) and by 55% at the highest concentration tested (P< 0.05; Fig 1A). At
concentrations >0.01 and<0.5 μg/mL cell viability was impaired by approximately 20%
(P< 0.05). Based on this, the response of FRTL-5 cells to TM in the subsequent experiments
was investigated at concentrations from 0.01 to 0.1 μg TM/mL.
Induction of ER stress by TM in FRTL-5 cells was evaluated by determining the mRNA
and/or protein levels of several ER stress/UPR target genes, the phoshorylation of ER stress
sensor PERK and its downstream phosphorylation target eIF2α and the splicing of XBP-1,
all of which are indications of ER stress [47]. As shown in Fig 1B, the mRNA and/or protein
levels of the UPR target genes activating transcription factor 4 (ATF4), BCL2 associated X,
apoptosis regulator (BAX), glucose-regulated protein, 78kDa (GRP78/BiP) and C/EBP
homologous protein (CHOP) were induced by 24 h treatment with TM at concentrations of
0.05 μg/mL and above, whereas no response to TM was observed at a TM concentration of
0.01 μg/mL. Induction of all UPR target genes tested was greater at 0.1 μg TM/mL than at
0.05 μg/mL. In line with the effect of TM on UPR target gene induction, the relative protein
level of p-PERK was increased by TM at concentrations of 0.05 μg/mL and above by 6–7 fold
(P < 0.05), whereas the protein level of total PERK was largely unchanged (Fig 1C). Phos-
phorylation of PERK and thus initiation of PERK signaling is a key event of ER stress induc-
tion. It is mediated by dissociation of BiP from the PERK sensing domain localized to the ER
lumen and thereby leads to the activation/phosphorylation of PERK through a mechanism
involving autophosphorylation of the cytosolic PERK kinase domain. Subsequently, the
ER stress and thyroid hormone synthesis
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active, p-PERK kinase selectively phosphorylates the serine 51 residue of eIF2α [48] leading
to inactivation of eIF2α and thus inhibition of ribosomal translation initiation and transient
attenuation of new protein synthesis [49]. Thus, phosphorylation of eIF2α is a further sensi-
tive indicator of ER stress and activation of the UPR. In agreement with PERK phosphoryla-
tion by TM, the relative protein level of p-eIF2α was elevated at 0.05 and 0.1 μg TM/mL
(P < 0.05; Fig 1C), but not at 0.01 μg/mL, whereas the protein level of total eIF2α was not
influenced by TM. Finally, ER stress induction by TM in FRTL-5 cells was evidenced from
the occurrence of unconventional splicing of XBP-1, another key event of ER stress signaling
Fig 1. ER stress inducer tunicamycin impairs cell viability and activates the unfolded protein response in FRTL-5 cells. Effect of 24-h treatment
of FRTL-5 thyrocytes with different concentrations of tunicamycin (TM) on: (A) cell viability, (B) mRNA and/or protein levels of the unfolded protein
response (UPR) target genes activating transcription factor 4 (ATF4) 4, BCL2 associated X, apoptosis regulator (BAX), glucose-regulated protein, 78kDa
(GRP78/BiP) and C/EBP homologous protein (CHOP), (C) protein levels of protein kinase RNA-like ER kinase (PERK) and p-PERK, eukaryotic initiation
factor 2α (eIF2α) and p-eIF2α, and (D) splicing of X-box binding protein (XBP)-1. (A-D) Cells treated with DMSO used as vehicle served as control. (A)
Bars represent cell viability relative to control (0 μg/mL TM), which was set to 100%, and are means ± SD from 3 independent experiments. (B, C) Bars
represent relative mRNA or protein levels expressed as fold of control (0 μg/mL TM), which was set to 1.0, and are means ± SD from 3 independent
experiments. One representative immunoblot for BAX, BiP, CHOP, PERK, p-PERK, eIF2α and p-eIF2α and β-Actin from three independent experiments
is shown. (D) Representative image of XBP-1 activation by unconventional splicing in FRTL-5 cells demonstrating the unspliced (192 bp) and the spliced
(s; 166 bp) XBP-1 mRNA as detected by conventional PCR followed by agarose gel electrophoresis. Actin beta (ACTB) was detected by conventional
PCR and served as a loading control for agarose gel electrophoresis. *Different from control (P < 0.05).
https://doi.org/10.1371/journal.pone.0187561.g001
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caused by the ER stress transducer IRE1. Subsequent translation of sXBP-1 mRNA into the
active transcription factor sXBP-1 causes activation of promoters of genes encoding ER
chaperones and ERAD components [8]. ER chaperones and ERAD components help to
restore ER homeostasis through facilitating protein folding and attenuating accumulation
of misfolded proteins [5,6]. As shown in Fig 1D, a 166-bp PCR product representing the
sXBP-1 mRNA could be observed in FRTL-5 cells treated with 0.05 and 0.1 μg TM/mL. No
sXBP-1 mRNA was observed in FRTL-5 cells treated with 0.01 μg TM/mL and in control
cells. These results clearly showed that TM induces ER stress in FRTL-5 cells in a dose-
dependent manner.
ER stress attenuates the expression of genes involved in thyroid
hormone synthesis and reduces iodide uptake in FRTL-5 cells
The effect of ER stress on expression of genes involved in thyroid hormone synthesis was
investigated in FRTL-5 cells treated for 24 h with the same TM concentrations as above. As
shown in Fig 2A, the mRNA levels of NIS, TG and TPO were reduced by about 30 to 50% by
TM at a concentration of 0.1 μg/mL (P< 0.05). This result is in agreement with earlier obser-
vations that different ER stress inducers decrease the expression of genes involved in thyroid
hormone synthesis, like TG [10] and NIS [50]. At concentrations of TM 0.05 μg TM/mL,
which were found to cause ER stress, no effect on expression of these genes was observed. This
indicates that the expression of genes involved in thyroid hormone synthesis in thyrocytes is
attenuated only during stronger ER stress but not during mild ER stress.
The inhibitory effect of TM on NIS mRNA level was also translated to the protein level as
demonstrated by the finding that the protein level of NIS was also reduced by the high concen-
tration of TM by approximately 30% as compared to vehicle control cells (P < 0.05; Fig 2B).
To study whether the decreased protein level of NIS reduces iodide uptake into FRTL-5 cells
during ER stress, the effect of TM was also investigated on Na125I uptake into FRTL-5 cells,
both in the presence and absence of KClO4 (1 mM), a specific inhibitor of iodide uptake via
NIS. In line with the decreased NIS expression by 0.1 μg TM/mL, total iodide uptake (absence
of KClO4) into FRTL-5 cells was reduced by 24 h treatment with TM at 0.1 μg/mL by about
30% (P< 0.05; Fig 2C), whereas lower concentrations of TM had no effect (Fig 2C). In the
presence of KClO4 in the culture medium, TM had no effect on Na125I uptake indicating that
TM inhibits NIS-specific iodide uptake.
While the inhibitory effect of TM on TPO mRNA level could not be verified at the protein
level due to the lack of an appropriate TPO-specific antibody, the effect of TM was also studied
on TG protein level. Immunoblotting with a TG-specific antibody revealed the detection of a
protein with a smaller size in FRTL-5 cells treated with 0.05 and 0.1 μg TM/mL than in control
cells and cells treated with 0.01 μg TM/mL (Fig 2D), in which a larger TG was detected. This
observation has been made earlier in FRTL-5 cells treated with TM [10,11] and is explained by
the fact that TM inhibits protein glycosylation [38]. Thus, the newly synthesized TG, which
accounts for greater than 50% of newly synthesized cargo proteins of thyrocytes [51] and
becomes glycosylated in the ER of the thyrocyte through addition of N-linked oligosaccharide
chains [52], was obviously not glycolysated in FTRL-5 cells treated with the high concentra-
tions of TM leading to a smaller (unglycosylated) TG protein. Besides glycosylation, TG
undergoes posttranslational modification by phosphorylation of carbohydrate chains (50%)
and serine (30%) and tyrosine residues (20%) [53]. Phosphorylation has been suggested to take
place in the Golgi complex and is thought to be important for directing TG through the Golgi
complex to the endosomes and, finally, to the lysosomes [54]. To study the effect of ER stress
on phosphorylation of TG in FRTL-5 cells, proteins were isolated also from TM-treated FRTL-
ER stress and thyroid hormone synthesis
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Fig 2. ER stress attenuates the expression of genes involved in thyroid hormone synthesis and reduces iodide
uptake in FRTL-5 cells. Effect of 24-h treatment of FRTL-5 thyrocytes with different concentrations of tunicamycin (TM)
on: (A) relative mRNA levels of sodium/iodide symporter (NIS), thyroglobulin (TG) and thyroid peroxidase (TPO), (B)
protein level NIS, (C) Na125I uptake in the presence and absence of the NIS-specific inhibitor KClO4, (D) protein levels of
total and p-TG, and (E) relative mRNA level of TSH receptor (TSHR). (A-E) Cells treated with DMSO used as vehicle
ER stress and thyroid hormone synthesis
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5 cells using a buffer containing phosphatase-inhibitors. Fig 2D shows that in FRTL-5 cells
treated with TM concentrations of 0.05 μg/mL the amount of p-TG with the high molecular
size decreased compared to control cells and cells treated with 0.01 μg TM/mL. A phosphory-
lated form of TG with a lower molecular size was found only in cells treated with the high TM
concentrations, but the bands for the low molecular p-TG were markedly less strong than
those of high molecular size p-TG. These findings suggest that TM treatment of FRTL-5 cells
not only inhibits TG glycosylation, but also TG phosphorylation, despite the fact that TM obvi-
ously decreased TG availability for phosphorylation because of inhibition of TG glycosylation
which precedes phosphorylation.
To further study whether ER stress also affects the expression of the TSH receptor (TSHR),
which mediates the stimulatory effect of TSH on the expression of NIS, TG and TPO at the
transcriptional and/or posttranslational level [55,56], we determined the mRNA level of
TSHR. As shown in Fig 2E, treatment with TM at concentrations > 0.01 μg/mL reduced the
expression of TSHR in FRTL-5 (P< 0.05). Although we did not analyze key signaling proteins
downstream of TSHR such as protein kinase A, our observation suggests that TSH signaling in
the thyrocyte is likely impaired during ER stress and the impaired TSH signaling may contrib-
ute to the decreased expression of NIS, TG and TPO.
ER stress has divergent effects on transcriptional regulators of genes
involved in thyroid hormone synthesis in FRTL-5 cells
Transcriptional regulation of NIS, TPO and TG by TSH was found to involve binding sites for
TTF-1, TTF-2 and PAX-8 [21–25]. To study whether the inhibitory effect of ER stress of gene
expression of NIS, TPO and TG is accompanied by a decreased expression of these transcrip-
tion factors, the mRNA and protein levels of TTF-1, TTF-2 and PAX-8 were determined in
FRTL-5 cells treated with TM. As shown in Fig 3A–3C, the mRNA and protein levels of all
three TSH-dependent transcription factors were reduced in cells treated with 0.1 μg TM/mL
(the protein levels of TTF-1 and PAX-8 even at 0.05 μg TM/mL) (P< 0.05), but not in cells
treated with lower TM concentrations and in control cells. These findings indicated that the
reduced expression of genes involved in thyroid hormone synthesis in response to ER stress
induction in FRTL-5 cells involves down-regulation of critical regulators of these genes.
Whether this effect is due to the impaired TSHR expression/TSH signaling or due to a direct
effect of ER stress on the expression of TTF-1, TTF-2 and PAX-8 cannot be answered from the
present data and requires further investigations.
Despite the well known role of TTF-1, TTF-2 and PAX-8 in regulating genes involved in
thyroid hormone synthesis, we have recently identified SREBP-1c and SREBP-2 as novel tran-
scriptional regulators of NIS, TPO and TG [27–29]. Using reporter gene, DNA binding and
chromatin immunoprecipitation assays, we could identify specific SREBP binding sites, called
sterol response elements (SRE), within different regulatory regions of NIS, TPO and TG [27–
29]. While SREBPs were initially discovered as master transcription factors of cholesterol, fatty
acid, triacylglycerol and phospholipid synthesis [26], the data from our group indicated that
SREBPs have functions beyond lipid synthesis, such as hormone synthesis, at least in the thy-
roid. Interestingly, we have also found recently that expression and activation of SREBP-1c
and SREBP-2 is stimulated by TSH in FRTL-5 thyrocytes [27], an effect that mechanistically
served as control. (A, B, D, E) Bars represent relative mRNA or protein levels expressed as fold of control (0 μg/mL TM),
which was set to 1.0, and are means ± SD from 3 independent experiments. (C) Bars represent counts per minute/well and
are means ± SD from 3 independent experiments. (D) One representative immunoblot for total TG, p-TG and β-Actin from
three independent experiments is shown. *Different from control (P < 0.05).
https://doi.org/10.1371/journal.pone.0187561.g002
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Fig 3. ER stress reduces the expression of critical regulators of genes involved in thyroid hormone
synthesis in FRTL-5 cells. Effect of 24-h treatment of FRTL-5 thyrocytes with different concentrations of
tunicamycin (TM) on relative mRNA and protein levels of: (A) (TTF)-1, (B) forkhead box E1 (FOXE1, also
named TTF-2), and (C) paired box-8 (PAX-8). (A-C) Cells treated with DMSO used as vehicle served as
control. Bars represent relative mRNA or protein levels expressed as fold of control (0 μg/mL TM), which was
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explains earlier observations that TSH stimulates the synthesis of cholesterol and fatty synthe-
sis in thyrocytes [57–59]. Since these lipids are important membrane constituents required for
thyrocyte growth and proliferation both of which are stimulated by TSH, we have proposed
recently that TSH-dependent stimulation of SREBPs aims to coordinate lipid and thyroid hor-
mone synthesis in growing and proliferating thyrocytes [27].
Several studies using cells from non-thyroidal tissues demonstrated that ER stress causes
proteolytic activation of SREBP-1c and thereby promotes de novo lipogenesis [33,34]. The
physiological meaning of the ER stress-induced activation of SREBP-1c pathway is that the
expansion of the ER during the UPR requires an additional provision of fatty acids in order to
synthesize the necessary phospholipids. In contrast to these observations from non-thyroidal
tissues/cells, we found that TM at concentrations > 0.01 μg/mL increased the mRNA level of
SREBP-1c and the protein level of the inactive pSREBP-1, but did not increase the protein
level of the transcriptionally active nSREBP-1 (Fig 4A). In line with the latter, the mRNA levels
of two known SREBP-1c target genes, FASN and GPAT, were not increased by TM. These
results indicated that proteolytic activation of SREBP-1c is not stimulated during ER stress in
FRTL-5 thyrocytes, despite strong transcriptional activation of the SREBP-1c gene under ER
stress. We cannot explain the lack of proteolytic activation of SREBP-1 in FRTL-5 thyrocytes
under ER stress conditions, but it may be speculated that this is due to the impairment of
TSH/TSHR signaling because we have recently shown that TSH stimulates proteolytic process-
ing of pSREBP-1 in FRTL-5 cells [27].
Our hypothesis with regard to the effect of ER stress on SREBP activation could also not
be confirmed in the case of SREBP-2, which is mainly responsible for regulating genes
involved in cholesterol synthesis and uptake [26]. Obviously, expression and proteolytic
activation of SREBP-2 is reduced during ER stress in FRTL-5 cells, as evident from decreases
of the mRNA level of SREBP-2 and protein levels of pSREBP-2 and nSREBP-2 and the
reduced mRNA levels of the SREBP-2 target genes HMGCR and LDLR following treatment
with the highest concentration of TM tested (P < 0.05; Fig 4B). Since SREBP-2 was recently
described as a transcriptional regulator of NIS, TG and TPO [27–29], it is possible that the
reduced expression of SREBP-2 during ER stress contributes, at least partially, to the down-
regulation of genes involved in thyroid hormone synthesis in FRTL-5 thyrocytes treated
with TM.
Conclusion
In conclusion, our findings show that the expression of key genes involved in thyroid hormone
synthesis and their critical transcriptional regulators is attenuated in thyrocytes during mild
ER stress, which is not associated with induction of apoptosis. Since the expression of TSHR
was also reduced in thyrocytes under ER stress conditions and both, genes involved in thyroid
hormone synthesis and transcriptional regulators of these genes are subject to regulation by
TSH, we suggest that ER stress causes down-regulation of NIS, TG and TPO through impaired
TSH/TSHR signaling in concert with reduced expression of TTF-1, TTF-2, PAX-8 and
SREBP-2. Our observation that ER stress causes down-regulation of genes involved in thyroid
hormone synthesis in thyrocytes might provide a mechanistic link between the presence of ER
stress-induced UPR in human congenital hypothyroid goiter [11], in a mouse model of con-
genital hypothyroid goiter [12,13] and in cystinotic thyroids in a mouse model of cystinosis
developing hypothyroidism [14].
set to 1.0, and are means ± SD from 3 independent experiments. (A-C) One representative immunoblot for
TTF-1, TTF-2, PAX-8, β-Actin and vinculin is shown. *Different from control (P < 0.05).
https://doi.org/10.1371/journal.pone.0187561.g003
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Fig 4. ER stress has divergent effects on SREBP-1c and SREBP-2 pathway in FRTL-5 cells. Effect of
24-h treatment of FRTL-5 thyrocytes with different concentrations of tunicamycin (TM) on: (A) relative mRNA
levels of sterol regulatory element-binding protein-1c (SREBP-1c) and its target genes fatty acid synthase
(FASN) and glycerol-3-phosphate acyltransferase, mitochondrial (GPAM), and on protein levels of precursor
(p) and nuclear (n) SREBP-1, and (B) relative mRNA levels of sterol regulatory element-binding protein-2
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